Last updated on October 2018

To Evaluate the Efficacy and Safety of FE 999315 in Japanese Subjects With Mild to Moderate Active Ulcerative Colitis


Brief description of study

To demonstrate non-inferiority in efficacy of FE 999315 to mesalazine in patients with mild to moderate active ulcerative colitis after 8 weeks of treatment.

Clinical Study Identifier: NCT03412682

Contact Investigators or Research Sites near you

Start Over

Global Clinical Compliance

Ferring Investigator Site JPN24
Koga-shi, Japan
  Connect »